Abstracts

NEUROPSYCHIATRIC ADVERSE EVENTS ASSOCIATED WITH INTEGRASE STRAND TRANSFER INHIBITORS

The increased use of INSTI based regimens over PI or NNRTI based regimens is largely due to the potency and safety of INSTIs. Case reports of new-onset or worsening of neuropsychiatric conditions, particularly depression and suicidality, have emerged with INSTIs. These reports prompted FDA to investigate the relationship between INSTIs and neuropsychiatric adverse events (NPAE),…

SMALL-MOLECULE INHIBITION OF INTRINSIC STRESS PATHWAYS REDUCES HIV TRANSCRIPTION

Combination antiretroviral therapy (cART) effectively reduces HIV replication to undetectable levels, but HIV persists as a stable reservoir within resting memory CD4+ T cells. Substantial effort has been applied to identifying small molecules that can perturb the stability of this reservoir. Studies in model systems have identified many latency reversing agents (LRAs), but few are…

NNRTIs DECREASE HIV-1 PRODUCTION FROM RCD4+ T CELLS FOLLOWING LATENCY REVERSAL

Background: Therapeutic strategies which target the latent HIV-1 reservoir in resting CD4+ T cells of infected-individuals are always administered in the presence of combination antiretroviral (ART) therapy. In this study, we evaluated whether the different therapeutic classes of ARV drugs impacted HIV-1 latency reversal. Methods: Latency reversal was evaluated in a primary cell model of…